We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GB Sciences Inc (PK) | USOTC:GBLX | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00043 | 6.85% | 0.00671 | 0.005 | 0.0068 | 0.0068 | 0.005 | 0.005 | 81,311 | 21:00:06 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
Ellins Craig |
2. Issuer Name
and
Ticker or Trading Symbol
GB SCIENCES INC [ GBLX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Chief Innovation Officer |
3035 EAST PATRICK LANE, SUITE 9 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
LAS VEGAS, NV 89120 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 3/2/2017 | S | 74207 | D | $0.3482 | 2845793 | D | |||
Common Stock | 3/3/2017 | S | 25793 | D | $0.3483 | 2820000 | D | |||
Common Stock | 3/7/2017 | S | 35000 | D | $0.3577 | 2785000 | D | |||
Common Stock | 3/8/2017 | S | 65000 | D | $0.3477 | 2720000 | D | |||
Common Stock | 3/9/2017 | S | 100000 | D | $0.3292 | 2620000 | D | |||
Common Stock | 3/10/2017 | S | 25000 | D | $0.328 | 2595000 | D | |||
Common Stock | 3/13/2017 | S | 30000 | D | $0.3277 | 2565000 | D | |||
Common Stock | 3/14/2017 | S | 25000 | D | $0.3283 | 2540000 | D | |||
Common Stock | 3/15/2017 | S | 50000 | D | $0.3247 | 2490000 | D | |||
Common Stock | 3/16/2017 | S | 50000 | D | $0.3291 | 2440000 | D | |||
Common Stock | 3/20/2017 | S | 11810 | D | $0.3247 | 2428190 | D | |||
Common Stock | 3/21/2017 | S | 16630 | D | $0.3131 | 2411560 | D | |||
Common Stock | 3/27/2017 | S | 10800 | D | $0.304 | 2400760 | D | |||
Common Stock | 3/28/2017 | S | 12200 | D | $0.3114 | 2388560 | D | |||
Common Stock | 3/29/2017 | S | 21500 | D | $0.3304 | 2367060 | D | |||
Common Stock | 3/30/2017 | S | 15313 | D | $0.3201 | 2351747 | D | |||
Common Stock | 4/3/2017 | S | 27544 | D | $0.3365 | 2324203 | D | |||
Common Stock | 4/4/2017 | S | 20000 | D | $0.3344 | 2304203 | D | |||
Common Stock | 4/5/2017 | S | 34633 | D | $0.3162 | 2269570 | D | |||
Common Stock | 4/6/2017 | S | 8742 | D | $0.3053 | 2260828 | D | |||
Common Stock | 4/7/2017 | S | 10000 | D | $0.2971 | 2250828 | D | |||
Common Stock | 4/10/2017 | S | 32100 | D | $0.3082 | 2218728 | D | |||
Common Stock | 4/11/2017 | S | 32100 | D | $0.2928 | 2186628 | D | |||
Common Stock | 4/17/2017 | S | 16068 | D | $0.3095 | 2170560 | D | |||
Common Stock | 4/18/2017 | S | 16068 | D | $0.294 | 2154492 | D | |||
Common Stock | 4/24/2017 | S | 7214 | D | $0.3012 | 2147278 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Ellins Craig
3035 EAST PATRICK LANE SUITE 9 LAS VEGAS, NV 89120 |
X |
|
Chief Innovation Officer |
|
Signatures
|
||
/s/ Craig Ellins | 6/16/2017 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year GB Sciences (PK) Chart |
1 Month GB Sciences (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions